Efficacy and Safety of XG-104 for the Treatment of Dry Eye

Completed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye

In brief

The objective of this study is to assess the safety and efficacy of XG-104 Ophthalmic Solution compared to placebo for the treatment of the signs and symptoms of dry eye after a 4 week Three Times a Day (TID) treatment period

Key facts

Study ID
NCT02235259
Run by
Xigen SA
People needed
260
Starts
2014-09-01
Expected to finish
2015-02-01
Last updated by the study team
2016-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.